Characteristics | Overall population N = 4445 | Nonsurvivorsa N = 2977 | Survivorsa N = 1468 | P valueb |
---|---|---|---|---|
Males, n (%) | 3112 (70) | 1999 (67) | 1113 (76) | < 0.001 |
Age (years), median [IQR] | 62 [51–73] | 64 [53–75] | 57 [48–68] | < 0.001 |
Witnessed, n (%) | 4001 (90) | 2591 (87) | 1410 (96) | < 0.001 |
Bystander CPR, n (%) | 2985 (75) | 1798 (69) | 1187 (85) | < 0.001 |
OHCA in a public area, n (%) | 1871 (42) | 1023 (34) | 848 (58) | < 0.001 |
Shockable rhythm, n (%) | 2217 (53) | 1053 (37) | 1164 (85) | < 0.001 |
No-flow timec (min), median [IQR] | 3.0 [0.0–8.0] | 5.0 [0.0–10.0] | 1.0 [0.0–5.0] | < 0.001 |
Low-flow timed (min), median [IQR] | 22 [14–35] | 26 [17–40] | 15 [10–23] | < 0.001 |
ST-segment elevation, n (%) | 1602 (45) | 866 (38) | 736 (56) | < 0.001 |
Epinephrine dose (mg), median [IQR] | 2.0 [0.0–4.0] | 3.0 [1.0–5.0] | 0.0 [0.0–1.0] | < 0.001 |
TTM, n (%) | 2300 (53) | 1425 (49) | 875 (62) | < 0.001 |
Vasoactive drugs, n (%) | 2735 (66) | 2060 (75) | 675 (49) | < 0.001 |
Successful angioplasty, n (%) | 1201 (27) | 614 (21) | 587 (40) | < 0.001 |
Lactate (mmol/L), median [IQR] | 5.8 [2.9–10.6] | 7.9 [4.4–12.5] | 2.9 [1.7– 4.8] | < 0.001 |
Creatinine (µmol/L), median [IQR] | 112 [86–145] | 126 [98–162] | 92 [75–116] | < 0.001 |
Patients treated with ECMO, n (%) | 528 (12) | 442 (15) | 86 (6) | <0.001Â |